Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

What Can We Expect after Performing Allogeneic Stem Cell Transplantation for Adult T Lymphoma in Patients from Romania, Europe?

Alina Daniela Daniela Tanase, Oana Gabriela Craciun, MD, Lavinia Lipan, Adela Ranete, Diana Laura Stefan, Zsofia Varady, MD PhD, Horia Bumbea, MD PhD, Andrei Colita, MD PhD, Olivier Hermine, Segiu Pasca, Patric Teodorescu, Ciprian Tomuleasa, MD

Blood (2019) 134 (Supplement_1): 5663.

https://doi.org/10.1182/blood-2019-126688

Published: 2019

Journal Articles

The Prognosis of Transformed DLBCL Were Superior to De Novo DLBL after the Relapsed/Refractory Status Related to the MYC Translocation

Yuko Mishima, PhD, Masahiro Yokoyama, MD, Noriko Nishimura, MD PhD, Yoshiharu Kusano, MD, Hideki Uryu, MD, Norihito Inoue, MD, Anna Nishihara, MD, Takanori Fukuta, MD, Yuko Shirouchi, MD, Naoko Tsuyama, MD PhD, Kengo Takeuchi, MD PhD, Yasuhito Terui, MD PhD

Blood (2018) 132 (Supplement 1): 5417.

https://doi.org/10.1182/blood-2018-99-111081

Published: 2018

Journal Articles

The Transition from Childhood to Adulthood in Chronic Immune Thrombocytopenia Patients: Clinical Management and the Role of Splenectomy and Thrombopoietin Receptor Agonists in a Single Center Experience

Monica Carpenedo, MD, Marco Spinelli, MD, Sara Pezzatti, MD, Momcilo Jancovic, MD, Rossella Renso, MD, Andrea Biondi, Carlo Gambacorti-Passerini, MD

Blood (2018) 132 (Supplement 1): 4987.

https://doi.org/10.1182/blood-2018-99-114050

Published: 2018

Journal Articles

Treatment Burden in Patients with Multiple Myeloma According to Comorbidity

Ernesto Pérez Persona, Ariane Unamunzaga Cilaurren, Ana Vega Gonzalez de Viñaspre, Itziar Oiartzabal Ormategui, Ana Santamaría Lopez, Laida Cuevas Palomares, Diego Robles de Castro, Carlos de Miguel Sanchez, Miren Gabilondo Jalón, Angel Pereda Vicandi, Arantza Mendizábal, Jose María Guinea de Castro

Blood (2018) 132 (Supplement 1): 4775.

https://doi.org/10.1182/blood-2018-99-112970

Published: 2018

Journal Articles

VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Definitive Results of a Randomized Phase 3 Pethema/GEM Study

Blood (2018) 132 (Supplement 1): 126.

https://doi.org/10.1182/blood-2018-99-111924

Published: 2018

Journal Articles

Second Transplants for Relapsed Acute Leukemia: Real World Experience from Argentina

Lucia Antonella Bet, MD, Mariano Berro, MD, Maria Ines Paganini, Ana Basquiera, MD, Silvina Palmer, MD, Juan Jose Garcia, MD, Juan Jose Real, Juliana Martinez Rolon, MD, Martin Castro, Gustavo Kusminsky, MD

Blood (2018) 132 (Supplement 1): 5740.

https://doi.org/10.1182/blood-2018-99-119909

Published: 2018

Journal Articles

Safety and Efficacy of Dasatinib Treatment Change for Patients Previosly Treated with Imatinib with Late Warning Response. Results from the Phase II, Open, Multicenter Dasapost Study

Valentín García-Gutierrez, MD, Felipe Casado, Fermín Sánchez-Guijo, MD PhD, Rosa M. Ayala, MD PhD, Concepcion Boque, PhD, Blanca Xicoy, MD, Isabel Montero, MD, Cesar Soto, Raquel De Paz, PhD, Joaquin Martinez-Lopez, Juan Luis Steegmann, MD

Blood (2016) 128 (22): 5450.

https://doi.org/10.1182/blood.V128.22.5450.5450

Published: 2016

Journal Articles

Prognostic Models Predictive of Disease Progression in CLL Patients Treated with Ibrutinib

Inhye E Ahn, MD, Xin Tian, Susan Soto, Janet Valdez, Jennifer Lotter, Mohammed Farooqui, Adrian Wiestner, MD PhD

Blood (2016) 128 (22): 187.

https://doi.org/10.1182/blood.V128.22.187.187

Published: 2016

Journal Articles

Assessment of Patients Fitness at Diagnosis in Elderly Acute Myeloid Leukemia

Semra Aydin, MD PhD, Ernesta Audisio, MD, Stefano D'Ardia, MD, Bernardino Allione, MD, Barbara Nicolino, MD, Alessandro Busca, MD, Chiara Dellacasa, MD, Giorgia Iovino, MD, Andrea Evangelista, MSc, Giovannino Ciccone, MD PhD, Umberto Vitolo

Blood (2016) 128 (22): 4012.

https://doi.org/10.1182/blood.V128.22.4012.4012

Published: 2016

Journal Articles

Challenge to Use the Interval Censorship Estimators for Time to Response Evaluation By Data from Chronic Myeloid Leukemia Registry

Sergey M. Kulikov, PhD, Irina A. Tischenko, Ekaterina Yu. Chelysheva, MD PhD, Olga V. Lazareva, PhD, Anna G. Turkina, MD PhD

Blood (2014) 124 (21): 3140.

https://doi.org/10.1182/blood.V124.21.3140.3140

Published: 2014

Journal Articles

Achieving Complete Cytogenetic Response and BCR-ABL PCR IS <1% within 12 Moths Are Important Goals for Imatinib Therapy in Newly Diagnosed, TKI-Naive Chronic Myeloid Leukemia Accelated Phase Patients

Hawk Kim, Eun-Jung Jang, Sung-Eun Lee, Won Sik Lee, MD PhD, Sukjoong Oh, MD PhD, Dong-Wook Kim, MD PhD

Blood (2014) 124 (21): 3158.

https://doi.org/10.1182/blood.V124.21.3158.3158

Published: 2014

Journal Articles

Clinical Characteristics and Outcomes in Patients with Multiple Myeloma and CKS1B Gene Gain/Amplification after Autologous Stem Cell Transplantation

Fabian M Bock, Gary Lu, MD, Nina Shah, Qaiser Bashir, Krina K. Patel, MD, Uday R. Popat, MD, Chitra M. Hosing, Sameh Gaballa, MD, Martin Korbling, MD, Ruby Delgado, Gabriela Rondon, MD, Robert Z. Orlowski, MD, PhD, Jatin J. Shah, Elisabet E. Manasanch, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD

Blood (2014) 124 (21): 2521.

https://doi.org/10.1182/blood.V124.21.2521.2521

Published: 2014

Journal Articles

NF-κB Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Blood (2014) 124 (21): 1620.

https://doi.org/10.1182/blood.V124.21.1620.1620

Published: 2014

Journal Articles

Western Intravascular Lymphoma (IVL): Case Series of Published Reports Between 1994-2014

Mohamad Khawandanah, MD, Bilal Ahmad, MD, Fahad Khan, MD, Jennifer L. Holter Chakrabarty, MD, Carrie Yuen, MD, George Selby, MD, Adam S. Asch, MD, Mohamad Cherry, MD

Blood (2014) 124 (21): 5417.

https://doi.org/10.1182/blood.V124.21.5417.5417

Published: 2014

Journal Articles

Combination Imatinib with Interferon-α For Philadelphia Positive Acute Lymphocytic Leukemia: A Mutiple Centers Study In China

Pu Kuang, MD, PhD, Yu Wu, MD, PhD, Bing Xiang, MD, Hongbing Ma, MD, Hong Chang, MD, Ting Niu, MD, PhD, Xu Cui, MD, Chuan He, MD, Jianjun Li, MD, Jie Ji, MD, Jie Huang, MD, Tian Dong, MD, PhD, Qing Shenglan, MB, Huaxin Wu, MB, Xiaogong Liang, MSc, Haiying Guo, MB, Chunnong Wu, MB, Ting Liu, MD

Blood (2013) 122 (21): 5019.

https://doi.org/10.1182/blood.V122.21.5019.5019

Published: 2013

Journal Articles

Characteristics and Outcome Of 66 Patients With Extramedullary Plasmacytomas (EMPs) Included In a Phase III Pethema/GEM Study Of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma (MM)

Laura Rosiñol, MD, Raquel Jiménez-Segura, Ana Isabel Teruel, MD, Javier De La Rubia, MD, PhD, Maria Victoria Mateos, MD, PhD, Miguel T. Hernandez, Dolores Hernández, M Jesús Blanchard, Belén Iñigo, Luis Palomera, MD, Isabel Krsnik, MD, PhD, Jose Francisco Tomas, MD, Norma C. Gutiérrez, Jesús F. San Miguel, MD, PhD, Juan José Lahuerta, Joan Blade, MD

Blood (2013) 122 (21): 3188.

https://doi.org/10.1182/blood.V122.21.3188.3188

Published: 2013

Journal Articles

Effects Of Noninherited Maternal Antigen On The Occurrence Of Acute Graft-Versus Host Diseae After Unmanipulated Haploidentical Blood and Marrow Transplantation

Ying-Jun Chang, Ph.D, Dai-Hong Liu, MD, PhD, Kaiyan Liu, Lan-Ping Xu, Yu Wang, Ming-Rui Huo, Huan Chen, Wei Han, MD, Yu-Hong Chen, Feng-Rong Wang, Jing-Zhi Wang, Yao Chen, Chen-Hua Yan, Xiao-Jun Huang, MD, PhD

Blood (2013) 122 (21): 3301.

https://doi.org/10.1182/blood.V122.21.3301.3301

Published: 2013

Journal Articles

Prognostic Significance Of a 4-Microrna Signature Targeting JAK2 In Classical Hodgkin Lymphoma

Alfons Navarro, PhD, Anna Gaya, MD, Anna Cordeiro, Msc, Blanca Gonzalez-Farre, MD, Marina Díaz-Beyá, MD, Dolors Fuster, Carmen Martinez, Jordi Esteve, MD, PhD, Antonio Martinez, MD, Mariano Monzó, MD, PhD

Blood (2013) 122 (21): 629.

https://doi.org/10.1182/blood.V122.21.629.629

Published: 2013

Journal Articles

Secondary Myelodysplasia-Associated Metaphase Cytogenetic Abnormalities in Newly Diagnosed Multiple Myeloma Treated On Total Therapies 2 & 3– Influence of Cumulative Dosing of Maintenance Drugs

Saad Z Usmani, MD FACP, Adam Rosenthal, Rachael Sexton, Antje Hoering, Zeba N Singh, MD, Sarah Waheed, MD, Al-Ola Abdallah, MD, Jameel Muzaffar, MD, Nathan M Petty, John Crowley, PhD, Jeffrey Sawyer, PhD, Joshua Epstein, DSc, Frits van Rhee, MD, PhD, Bart Barlogie, MD, PhD

Blood (2012) 120 (21): 324.

https://doi.org/10.1182/blood.V120.21.324.324

Published: 2012

Journal Articles

Systemic Relapses In Primary CNS Lymphoma (PCNSL) - Unexpected Clonal Diversity

Lars Fischer, Michael Hummel, Prof., Agnieszka Korfel, Dido Lenze, Kristoph Jahnke, Philipp Kiewe, Michael Weller, Prof., Eckhard Thiel, Prof.

Blood (2010) 116 (21): 3125.

https://doi.org/10.1182/blood.V116.21.3125.3125

Published: 2010

NARROW

What Can We Expect after Performing Allogeneic Stem Cell Transplantation for Adult T Lymphoma in Patients from Romania, Europe?

The Prognosis of Transformed DLBCL Were Superior to De Novo DLBL after the Relapsed/Refractory Status Related to the MYC Translocation

The Transition from Childhood to Adulthood in Chronic Immune Thrombocytopenia Patients: Clinical Management and the Role of Splenectomy and Thrombopoietin Receptor Agonists in a Single Center Experience

Treatment Burden in Patients with Multiple Myeloma According to Comorbidity

VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Definitive Results of a Randomized Phase 3 Pethema/GEM Study

Second Transplants for Relapsed Acute Leukemia: Real World Experience from Argentina

Safety and Efficacy of Dasatinib Treatment Change for Patients Previosly Treated with Imatinib with Late Warning Response. Results from the Phase II, Open, Multicenter Dasapost Study

Prognostic Models Predictive of Disease Progression in CLL Patients Treated with Ibrutinib

Assessment of Patients Fitness at Diagnosis in Elderly Acute Myeloid Leukemia

Challenge to Use the Interval Censorship Estimators for Time to Response Evaluation By Data from Chronic Myeloid Leukemia Registry

Achieving Complete Cytogenetic Response and BCR-ABL PCR IS <1% within 12 Moths Are Important Goals for Imatinib Therapy in Newly Diagnosed, TKI-Naive Chronic Myeloid Leukemia Accelated Phase Patients

Clinical Characteristics and Outcomes in Patients with Multiple Myeloma and CKS1B Gene Gain/Amplification after Autologous Stem Cell Transplantation

NF-κB Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Western Intravascular Lymphoma (IVL): Case Series of Published Reports Between 1994-2014

Combination Imatinib with Interferon-α For Philadelphia Positive Acute Lymphocytic Leukemia: A Mutiple Centers Study In China

Characteristics and Outcome Of 66 Patients With Extramedullary Plasmacytomas (EMPs) Included In a Phase III Pethema/GEM Study Of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma (MM)

Effects Of Noninherited Maternal Antigen On The Occurrence Of Acute Graft-Versus Host Diseae After Unmanipulated Haploidentical Blood and Marrow Transplantation

Prognostic Significance Of a 4-Microrna Signature Targeting JAK2 In Classical Hodgkin Lymphoma

Secondary Myelodysplasia-Associated Metaphase Cytogenetic Abnormalities in Newly Diagnosed Multiple Myeloma Treated On Total Therapies 2 & 3– Influence of Cumulative Dosing of Maintenance Drugs

Systemic Relapses In Primary CNS Lymphoma (PCNSL) - Unexpected Clonal Diversity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only